D-Health Innovation Tour
D-A-CH & Israel

The Future of Public-Private Collaboration & NetworkinG at the Intersection of SciencE
& Entrepreneurship

29th June 2021 | 9AM-4PM CET

Gold Sponsor: 

Hosted by:

This event takes place via Zoom

giin logo black.png

Bronze Sponsors: 

WhatsApp Image 2021-06-25 at 10.04.21.jp

Innovating means breaking new frontiers. In health care, more than elsewhere, the public & private sectors need to work hand-in-glove - enabling novel solutions in policy just in parallel to the smart new innovations breaking through to the patient, providers, pharma & payers.


There is no better time than now to reunite experts from top ranking innovation countries such as Israel, Germany, Switzerland & Austria to capitalize on digitally powered soft- & hardware solutions - sharing knowledge, research aims & entrepreneur solutions for better patient outcomes & more efficient health care systems.

Our goal is to discuss challenges & future opportunities in D-Health - fostering the interconnectivity between Israel's & D-A-CH experts in the realm of D-Health, Science & MedTech to lay the foundation for growing a community of practice.

Furthermore, this event aspires to:

  • share academic & industry knowledge between all participants for the benefit of smarter & faster patient-centered solutions

  • catalyze the dialogue between the different stakeholders in the health care & the emerging D-Health industry

  • showcase various approaches in cross-sector collaboration among public & private actors

  • enlarge your professional network to encourage long term cross-disciplinary & cross-cultural cooperation.

what to expect?

GIIN Icons Website blue2-19.png

Inspiring Keynote Speakers

GIIN Icons Website blue2-10.png

Co-Creation & Networking Opportunities

GIIN Icons Website blue2-11.png

Workshops with Leaders from D-A-CH

GIIN Icons Website blue2-12.png

Tech transfer from bench to market

GIIN Icons Website blue2-13.png

Panels & Start Up Pitches

for whom is this event?

waben v2 b.png


Amos Tanay-2.jpg
Amos Tanay

After conducting postgraduate research at Rockefeller University, Prof. Amos Tanay joined the Weizmann Institute in 2007 where  he serves as the Scientific Director of the Ilana and Pascal Mantoux Institute for Bioinformatics and leads the Bench-to-Bedside program. Within his group, they develop single cell genomics techniques to characterize the molecular activity and epigenetics of cells and then apply mathematical methods to understand how they function within the body. Prof. Tanay has received a number of prestigious awards, including the 2013 Helen L. and Martin S. Kimmel Award for Innovative Investigation, the 2012 Krill Award for Excellence in Scientific Research, the European Molecular Biology Organization (EMBO) young investigator award (2010), the Morris L. Levinson Prize in Mathematics (2010), and the Rothschild Postdoctoral Fellowship (2006).


Assaf Parker.jpg
Assaf Parker

As the Head of Digital Health Technologies Department within the Israeli Ministry of Health, Assaf leads multiple digital health initiatives. Ranging from concept design to implementation, Assaf is dedicated to finding innovative digital health solutions for national organizational challenges. Assaf and his team are cultivating cross-sector collaborations, designing solutions and enabling technological integration to enhance digital

transformation. This includes challenge tenders and financial incentive programs for digital technology implementation, and upscaling initiatives. The goal is to empower patients and health organizations to provide better

healthcare. Assaf brings experience from the private sector, especially management operations, customer relations and economics. He holds a B.A. in Economics and Business Administration from Ben Gurion University and a B.Sc in Industrial Engineering and Management from Afeka College.



David Matusiewicz.jpg
David Matusiewicz

David Matusiewicz is Professor of Medical Management at the FOM University – the largest private university in Germany. Since 2015, he has been responsible for the university sector Health & Social Affairs as Dean and as Director of the Research Institute for Health & Social Affairs (ifgs). In addition, he supports technology-driven start-ups in the healthcare sector as a founder or business angel. Matusiewicz is on various advisory boards and an investor in companies that deal with the digital transformation of the healthcare sector. Before taking up his professorship, he worked for several years as a research assistant at Prof. Dr. Jürgen Wasem at Alfried Krupp von Bohlen and Halbach Endowed Chair for Medical Management at the University of Duisburg-Essen.



Enise Lauterbach
Enise Lauterbach

Dr. Enise Lauterbach is a cardiologist and entrepreneur. She is co-founder and CEO of LEMOA medical.

Her startup implements digital innovations to improve healthcare. For optimised healthcare, she focuses on communication technologies, such as instant messaging and e-health platforms, which have so far played a subordinate role in the German healthcare system.

The autonomy of patients and self-efficacy through active participation in the treatment process is an important therapeutic approach for the cardiologist. She developed a digital health app for patients with heart failure. 

The Digital Health Hub Trier, which she also founded, supports the regional digitalisation of healthcare. Her goal is to establish new forms of care that contribute to equitable access to healthcare. She is co-initiator of the 1st Healthcare Hackathon in Trier.



Eyal Zimlichman
Eyal Zimlichman

Prof. Eyal Zimlichman serves as Deputy Director General, Chief Medical Officer, and Chief Innovation Officer at Sheba Medical Center. Previously, he held the position of Lead Researcher at Partners HealthCare's Clinical Affairs Department in Boston. Prof. Zimlichman has served on several advisory committees at the U.S. Department of Health and Human Services and is chairing in several committees at Israel's Ministry of Health. He is also a founding member of the International Academy for Quality and Patient Safety. Prof. Zimlichman is the founder and director of Sheba's ARC innovation program. He is board certified in internal medicine, completed a degree at the Harvard T.H. Chan School of Public Health, and has earned his MD at the Technion Israel Institute of Technology.



Hanna Boëthius.jpg
Hanna Boëthius

Hanna Boëthius has lived with Type 1 Diabetes as her constant companion for 36 years, and is a patient leader, international speaker, MSc Diabetes student and action taker, who loves patient topics that are off of the beaten track. She’s passionate to find motivational and inspiring ways to bring about a change in health care. Through her own company, Hanna Diabetes Expert, she’s inspired thousands of people with diabetes to live a healthier life by sharing her own story and experiences. She has a profound understanding of how things like nutrition and lifestyle choices can balance diabetes management. She is also the founder of the interactive, 100% real food event, The Low Carb Universe. It’s Europe’s healthiest event!



Isabelle Juchler_NeNI.JPG
Isabelle Juchler

Isabelle Juchler brings a multifaceted experience of over 13 years in the MedTech and Hospital sector. She has held various roles of responsibility in strategic management, new technology deployment and innovation management in health care. In both operational and consulting roles, her passion is to drive a sustained culture change to make healthcare more agile, efficient and digital. She is a core member of NeNI, the Swiss National e-health Network Initiative, a do-tank knowledge hub by and for a collaborative consortium of stakeholders who want to shape a health care system with the patient at the center. With a steady ecosystem perspective, Isabelle is passionate about innovation and digitalization as important drivers to make the patient experience truly experiential. 



Julia Hagen

Julia Hagen is the Director Regulatory and Politics at the hih, health innovation hub Berlin, supporting the German Ministry of Health in the deployment of the Digital Health Strategy. She has been a core member developing the policy frameworks for the globally leading patient-centered mobile health applications - DiGA: digitale Gesundheitsanwendungen - the German therapeutic digital apps on demand. Beforehand, she was responsible for Health and Pharma at Bitkom, Germany’s leading digital association, where she similarly focussed on regulatory policy frameworks to make novel digital solutions in health care a reality. Julia Hagen holds an MPA from London School of Economics and a Master of Public Affairs from Sciences Po in Paris. 



Jürgen Brandstätter
Jürgen Brandstätter

As a passionate proponent of "standards-based interoperability" in Health IT, Jürgen Brandstätter calls himself a Standards Expert. He is active in several standardization organizations at national and international level, in particular as the Co-Chair of IHE Europe. Dipl.Ing. Jürgen Brandstätter contributed to the European epSOS project and to the Austrian eHealth Infrastructure project (ELGA). Furthermore, he participates in the Global Digital Health Partnership on behalf of the Austrian Federal Ministry of Social affairs, Health, Care and Consumer Protection. Internationally, he actively contributes to various interoperability projects such as the Swiss Electronic Patient Dossier, the Greek National eHealth Information Framework project. Furthermore, he actively works on the promotion of IHE in Asia-Pacific in collaboration with the Asian Development Bank.



Nadav Davidovitch

Prof. Nadav Davidovitch is an epidemiologist, public health physician and Head of Ben-Gurion University of the Negev’s School of Public Health. He has served as Chair of the Department of Health Systems Management at the University and the Center for Health Policy Research in the Negev and is Chair of the Association of Public Health Physicians in Israel, a member of various committees of the Israeli Ministry of Health and various international committees including the Task Force on the Coronavirus of the European Association of the School of Public Health. Prof. Davidovitch has authored many articles and books on the subject of public health, health policy, health economics, health systems management, ethics and sociology of health. Since the outbreak of COVID-19 in Israel, he has been involved in research and the formulation of health policy and has advised various agencies in Israel and abroad on the need to make structural changes in the health system, with an emphasis on social issues and addressing health gaps.



Nakisa Serry-GALDERMA 0861R.jpg
Nakisa Serry

Nakisa Serry, JD, LLM serves as General Counsel and Chief Compliance Officer of Galderma. She leads Galderma’s legal, intellectual property and ethics and compliance team, which supports the three businesses as they execute on the company’s strategic priorities. Previously, Nakisa spent fourteen years at Celgene, whereas Corporate VP & Associate GC, she had responsibility for the worldwide markets legal team supporting the ex-US region. Prior to joining Celgene, Nakisa was General Counsel and Corporate Secretary at orthobiologics company IsoTis SA, and prior to that she was legal counsel at GSK in Belgium. She also spent a year with the Children's Vaccine Initiative at the WHO and seven years in private practice at the law firm Hoogendoorn & Talbot in Chicago, US.



Opher Shapira
Opher Shapira

Dr. Opher Shapira is a serial entrepreneur with more than 25 years of executive experience in the Israeli high-tech sector. In 2020, he was appointed CEO of the Yeda Research and Development Technology transfer from the Weizmann Institute of Science.

After obtaining a PhD in theoretical high energy physics from Yale University in 1991, Dr. Shapira began his professional career as R&D person moving up to the position of VP R&D. After several such years he established his first company BioView which he led to a successful IPO.

Until assuming the current position Opher led several successful transfers of private Startup companies to international public listings in the realm of biomedical, medical device and diagnostic technologies (Nanergy Alternative Energy, Syneron Medical, Nucleix).



Roey Eldan
Roey Eldan

Roey Eldan is an experienced Director of Business Development with a demonstrated history of working with information technology and SaaS platforms in the Healthcare space. Roey’s passion for the healthcare and remote patient monitoring has brought Datos Health the forefront of many important and fruitful partnerships.



Shani Toledano
Shani Toledano

Shani has a B.Sc. in Mechanical Engineering with a specialization in heat transfer and thermodynamics, and M.Sc in Artificial Intelligence.

Shani has over 11 years of experience in the tech, defence & aviation industry as a developer, system engineer, and R&D team leader. Shani was laureate of the “Forbes 30 under 30” and globs "40 under 40".

Today Shani is the CEO of HT BioImaging, a medical imaging technology company with a mission to detect and classify cancer early on the spot.



Univ.-Prof. Dr. Siegfried Meryn.jpg
Siegfried Meryn

Professor Dr. Meryn is the initiator of Future Health Lab and Health Digital City Vienna. As a serial innovator, he drives multiple initiatives in the realm of digital, health and societal impact.

For his far-reaching career as a clinician, physician and leader in health care, he has earned the highest Austrian honors (Ehrenzeichen für Verdienste der Republik Österreich und des Landes Wiens).

Siegfried Meryn is a Professor emeritus of the Medical University Wien and has been trained at renowned International institutions such as The Kings College in London and the Albert Einstein College in New York.

He regularly speaks in public and social media and entertains several solution-oriented public discussions in the format of podcasts, webinars and interactive multistakeholder platforms.



Sylvia Thun
Sylvia Thun

As a double certified medical doctor and engineer, Slyvia Thun is the Professor for Information and Communication Healthcare Technology at the Niederrhein University of Applied Sciences where she heads the eHealth competence center. In Berlin, she is the Charité Visiting Professor and head of the eHealth & Interoperability Core unit at the Berlin Institute of Health (BIH). Prof Thun holds several honors including the award of "digital head" of the Gesellschaft für Informatik and the additional designation "Medical Informatics" from the North Rhine Medical Association. She is active in chairing IT standards in healthcare within the SITiG and HL7 as well as the DIN medical informatics committee and is a delegate to ISO TC 215 "Medical informatics" and CEN TC 215.



Thomas Hefti.JPG
Thomas Hefti

Thomas Hefti gained a PhD in economics from the University of St. Gallen in Switzerland. He started his career in Roche in Basel where he collected broad experience in different headquarter global and local roles. He then moved on to set up the Swiss affiliate for Celgene, launching Revlimid®, followed by various International roles of increasing responsibility in hematology, oncology and rare diseases. In 2015, he joined Novocure as the Senior Vice President for Europe and Israel, building a successful business in Glioblastoma, a rare form of brain cancer, for Optune® (Tumor Treating Fields).



Tonio Schönfelder

Tonio Schönfelder is the Head of Health Services Research at the Scientific Institute for Health Economics and Health Systems Research (WIG2) – a private research institute based in Germany. He has been working on the measurement and evaluation of quality in health care for many years, with a focus on digital health innovations, especially „DiGA“. His work also focuses on German care structures, evidence analysis and market access strategies. In parallel, Dr. Schönfelder is a visiting lecturer at the Chair of Health Sciences and Public Health at the Technical University of Dresden, where he is also completing his habilitation.


Toralf Schnell

Toralf Schnell holds a MAS in Digital Business. With over 20-years of work experience in the digital business, business intelligence and digital analytics area, he has lived and worked in Germany, Switzerland, and the US. He has previously successfully co-founded and sold an eCommerce StartUp business.

Since November 2018, he has been holding the position of Chief Digital Officer at the University Hospital Greifswald and since November 2019 is the dedicated Digital Ambassador of the region Mecklenburg-Vorpommern. His passion is “Connecting the Dots” by mapping digital capabilities to strategic priorities and replacing manual processes with technology and digital innovations.



Uri Weinberg.jpg
Uri Weinberg

Dr. Uri Weinberg currently serves as Novocure’s Chief Science Officer overseeing early-stage research and development as well as the design, development and implementation stages of all clinical trials. Since joining Novocure in 2008, he has held several positions throughout his tenure with the company. Dr. Weinberg managed Novocure’s first clinical trial in lung cancer as well as the EF-14 clinical trial in newly diagnosed glioblastoma and built the company’s global Clinical Operations team in Switzerland. Dr. Weinberg most recently held the position of Vice President of Clinical Development where he was responsible for expanding research activities, strengthening global clinical collaboration and initiating new discovery programs. Dr. Weinberg holds an MD/PhD from the Technion - Israel Institute of Technology.



Walid Ahmed_NeNI.jpg
Walid Ahmed

Walid S. Ahmed (Dipl. Biol.; Managing Partner at Bright Insight GmbH and CEO at NeNI) owns more than 20 years of experience in the elicitation, specification and implementation of digital systems and regulatory policies in healthcare. As former section head e-Health at the Swiss Federal Office of Public Health (BAG), he is deeply familiar with the technical, organisational and legal requirements and challenges regarding the Swiss electronic patient record (EPR / EPD). Working at the implementation frontier of D-Health solutions as well as on federal regulations, he has seen both sides. He is driven by the purpose to create trust and value through collaboration and to guide organisations in building secure and privacy respecting frameworks.



Yaron Daniely
Yaron Daniely 

Dr. Yaron Daniely is a Partner at aMoon & Head of aMoon Alpha.

Before joining aMoon, Dr. Daniely was President & CEO of Yissum, and the co-chairperson of the Israel Technology Transfer Network – ITTN. Before joining Yissum in 2017, he spent 14 years as a senior executive (incl. 10 years as CEO) in private NASDAQ-traded Biopharma and Biotech companies.

Yaron earned his PhD from the Sackler Institute of Graduate Biomedical Sciences at the NYU School of Medicine. Following his doctoral program, Yaron served as a Visiting Fellow at the NIH, and as an American Cancer Society Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science in Israel. Yaron also holds an MBA degree from the Technion-Israel Institute of Technology.



Yossi Bahagon.jpg
Yossi Bahagon

Dr. Bahagon is a clinically active family physician, serial entrepreneur, and global key opinion leader in digital health.
Dr. Bahagon founded and managed Clalit Health Services' (CHS) digital health division. CHS is the second largest Health Maintenance Organization in the world and serves millions of patients monthly.
Dr. Bahagon has also been a founding team member of several successful digital health companies. Following the acquisition of his first company, he founded Qure Ventures – Israel's first digital health focused fund.
Dr. Bahagon serves as a special advisor for the World Health Organization, as well as an Advisory Board member of Best Buy Health and Almirall Pharmaceuticals, and a mentor at Microsoft's Think-Next Accelerator and Biocat's Digital Health Accelerator.



your hosts and moderators

Jenny Havemann
Jenny Havemann

Jenny Havemann is CEO and Co-Founder of GIIN - German-Israeli Innovation Network and is working in the area of German-Israeli relations for many years. She is bringing together politicians, entrepreneurs, journalists and companies from Germany, Austria, Switzerland and Israel together. She also gives lectures about various topics such as Israeli politics, innovation, antisemitism and feminism. Together with Susanne Glass, she founded an Israeli-European Media Summit „Media TLV“.



Tina Horsky
Tina Horsky

Tina Horsky is the CEO and Co-Founder of GIIN – German-Israeli Innovation Network. She is driven by the purpose to create cross-cultural collaboration and understanding by initiating multifaceted initiatives between D-A-CH and Israel. She has been operating and learning from experiences as a startup entrepreneur and business executive in the e-commerce and tech advertising industry as well as in the non-profit world in the US and Europe. As a German native, married to an Israeli, Tina Horsky has lived and worked in multiple continents for the last 17+ years (Europe, US, Middle East) She holds a Master of Integrated Marketing Communications from Loyola University Chicago as well as a Master of Education from the Ludwig-Maximilians-University in Munich.



Verena Voelter.png
Verena Voelter

Dr. Verena Voelter is a passionate oncologist and entrepreneur. With over 25 years’ experience at the forefront of healthcare, she has held key positions as an attending clinician researcher in the hospital, and as an executive leader in pharma (Celgene, Novartis). With her unique views on the public and private sectors, she strongly believes in collaboration as the key to unlock the quandary in health care among patients, providers, pharma, payers and policymakers. Today, she brings credibility as a neutral mediator, executive coach and teacher to the benefit of all stakeholders, both as the founder of 5P Health Care Solutions® and as an Adjunct Professor at Northwestern. She is the author of ‘It Takes 5 to Tango in Health Care’.



29th June 2021

all times listed in cet

09:05 - 09:15

Connectivity between D-A-CH & Israel as a Catalyst for

D-Health Innovation

Jenny Havemann, Tina Horsky

09:15 - 09:25

The 5 Ps approach – What is it & Why is it Important?

Verena Voelter

09:25 - 09:45

MedTech at the Forefront of Science & Patient Needs

Uri Weinberg

09:45 - 10:00

How do Policymakers best Endorse D-Health? 3 views (D-A-CH)

Julia Hagen, Jürgen Brandstätter, Walid Ahmed

10:00 - 10:30

Panel #1 - Next Frontiers in Public-Private Collaboration,

Cross-talk on D-Health

Moderator: Jenny Havemann & Verena Voelter

Panelists: David Matusiewicz, Roey Eldan, Thomas Hefti, Yaron Daniely

10:45 - 11:00

Data privacy - Disabler or Enabler?

Nakisa Serry & Verena Voelter

11:00 - 11:30

Panel #2 - Smart Patient Centricity:

Digital Brings Back the Human Touch and Efficiencies to the System

Moderator: Isabelle Juchler & Verena Voelter

Panelists: Hanna Boëthius, Nadav Davidovitch, Toralf Schnell

11:30 - 12:00

Opportunities for Computational Science in D-Health

Amos Tanay

12:00 - 12:20

The Israeli Health Care System

Assaf Parker

Break (Interactive Networking)

Morning Summary

Jenny Havemann, Tina Horsky, Verena Voelter

13:15 - 13:35

How Digital Connections Enhance the Patient Experience & Efficiencies

Eyal Zimlichman

13:40 - 14:00

Get to Know: Israeli Startup pitches

HT BioImaging, Sight Diagnostics

14:00 - 14:15

Successful Tech Transfers from Bench to Market

Opher Shapira

14:15 - 15:15

Co-Creating New Solutions in 3 Parallel Interactive Workshops

  1. Shape The Future of Digital Therapeutics (DTx)

    Moderator: Tonio Schönfelder

  2. Deliver Patient Apps for MedTech & DTx solutions

    Moderator: Uri Weinberg

  3. Accelerate Your Tech Transfer - from Science to Business

    Moderator: Opher Shapira

15:15 - 15:45

Closing Panel #3: D-Health Outlook into the Future

Moderator: Tina Horsky & Verena Voelter

Panelists: Enise Lauterbach, Siegfried Meryn, Sylvia Thun, Walid Ahmed, Yossi Bahagon

15:45 - 16:00

Call for Action - Follow-up Projects - Networking - See You in 2022!

Jenny Havemann, Tina Horsky, Verena Voelter